These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 7349668
1. The characteristics of anticoagulation by covalently immobilized heparin. Miura Y, Aoyagi S, Kusada Y, Miyamoto K. J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668 [Abstract] [Full Text] [Related]
2. Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin. Miura Y, Aoyagi S, Ikeda F, Miyamoto K. Biochimie; 1980 Sep; 62(8-9):595-601. PubMed ID: 7417594 [Abstract] [Full Text] [Related]
3. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Elgue G, Blombäck M, Olsson P, Riesenfeld J. Thromb Haemost; 1993 Aug 02; 70(2):289-93. PubMed ID: 8236137 [Abstract] [Full Text] [Related]
4. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. Ofosu FA, Cerskus AL, Hirsh J, Smith LM, Modi GJ, Blajchman MA. Br J Haematol; 1984 Jun 02; 57(2):229-38. PubMed ID: 6733045 [Abstract] [Full Text] [Related]
10. Decreased heparin sensitivity of cyclohexanedione-modified factor Xa. Blaskó G, Machovich R. Thromb Haemost; 1979 Aug 31; 42(2):556-63. PubMed ID: 505364 [Abstract] [Full Text] [Related]
11. The effect of a sulfated polysaccharide on antithrombin III. Czapek EE, Kwaan HC, Szczecinski M. J Lab Clin Med; 1980 Jun 31; 95(6):783-90. PubMed ID: 6155418 [Abstract] [Full Text] [Related]
12. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo. Kudrjashov BA, Pastorova VE, Lyapina LA. Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Jun 31; 110(5):731-42. PubMed ID: 6198257 [Abstract] [Full Text] [Related]
13. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin. Blaskó G. Prostaglandins; 1979 Jul 31; 18(1):3-9. PubMed ID: 160589 [Abstract] [Full Text] [Related]
15. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells. Chan TK, Chan V. Thromb Haemost; 1981 Aug 28; 46(2):504-6. PubMed ID: 7302889 [Abstract] [Full Text] [Related]
16. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma. Rezaie AR. Thromb Res; 2007 Aug 28; 119(4):481-8. PubMed ID: 16515805 [Abstract] [Full Text] [Related]
17. Factor X. Jackson CM. Prog Hemost Thromb; 1984 Aug 28; 7():55-109. PubMed ID: 6397768 [No Abstract] [Full Text] [Related]
18. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model. Tseng PY, Rele SS, Sun XL, Chaikof EL. Biomaterials; 2006 Apr 28; 27(12):2637-50. PubMed ID: 16376423 [Abstract] [Full Text] [Related]
19. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Demers C, Henderson P, Blajchman MA, Wells MJ, Mitchell L, Johnston M, Ofosu FA, Fernandez-Rachubinski F, Andrew M, Hirsh J. Thromb Haemost; 1993 Mar 01; 69(3):231-5. PubMed ID: 8470046 [Abstract] [Full Text] [Related]
20. Effect of heparin on the activation of factor XI by fibrin-bound thrombin. von dem Borne PA, Meijers JC, Bouma BN. Thromb Haemost; 1996 Sep 01; 76(3):347-53. PubMed ID: 8883269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]